NCT03390686 - A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients | Biotech Hunter

Enrollment

650

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

July 1, 2024

Study Completion Date

December 31, 2025

Conditions

Lung CancerNon-small Cell Lung Cancer

Interventions

DRUG

Bevacizumab

15 mg/kg IV every 3 weeks on Day 1

DRUG

HD204

15 mg/kg IV every 3 weeks on Day 1

DRUG

Carboplatin

Carboplatin AUC 6 IV every 3 weeks on Day 1 for 4-6 cycles

DRUG

Paclitaxel

Paclitaxel 200 mg/m2 IV every 3 weeks on Day 1 for 4-6 cycles

Trial Locations (18)

1781

Asian Hospital and Medical Center, City of Muntinlupa

2045

Tudogyogyintezet Torokbalint, Törökbálint

5300

"MHAT Dr. Tota Venkova, AD", Gabrovo

6010

"LTD High Technology Hospital Medcenter", Batumi

15586

HRPZ II, Kota Bharu

21204

IPD of Vojvodina, Kamenitz

31000

CHC Osijek, Osijek

50200

Maharaj Nakorn Chiang Mai, Chiang Mai

57001

Interbalkan Hospital, Thessaloniki

65055

Oncology Dispensary, Odesa

95801

Nemocnica na okraji mesta, n.o., Partizánske

143422

MEDSI, Moscow

223040

Alexandrov Cancer Center, Minsk

422002

HCG Manavata Cancer Centre, Nashik

0159

Institute of Clinical Oncology, Tbilisi

Unknown

Riga East University Hospital Latvian Oncology centre, Riga

01748

Magodend Szpital Elblaska, Warsaw

01060

Acibadem Adana Hospital, Adana